Choksi Laboratories [CHOKSILA] vs Krsnaa Diagnostics [KRSNAA] Detailed Stock Comparison

Choksi Laboratories Ltd.

BSE
Loading...

Krsnaa Diagnostics Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Choksi Laboratories Ltd. wins in 7 metrics, Krsnaa Diagnostics Ltd. wins in 12 metrics, with 0 ties. Krsnaa Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Choksi Laboratories Ltd. Krsnaa Diagnostics Ltd. Better
P/E Ratio (TTM) 37.71 24.69 Krsnaa Diagnostics Ltd.
Price-to-Book Ratio 2.85 2.13 Krsnaa Diagnostics Ltd.
Debt-to-Equity Ratio 120.16 30.96 Krsnaa Diagnostics Ltd.
PEG Ratio 0.19 -1.15 Choksi Laboratories Ltd.
EV/EBITDA 8.86 10.20 Choksi Laboratories Ltd.
Profit Margin (TTM) 4.17% 10.49% Krsnaa Diagnostics Ltd.
Operating Margin (TTM) 7.41% 13.13% Krsnaa Diagnostics Ltd.
EBITDA Margin (TTM) 7.41% 13.13% Krsnaa Diagnostics Ltd.
Return on Equity 6.45% 8.79% Krsnaa Diagnostics Ltd.
Return on Assets (TTM) 2.33% 6.06% Krsnaa Diagnostics Ltd.
Free Cash Flow (TTM) $40.91M $-393.00M Choksi Laboratories Ltd.
Dividend Yield N/A 0.62% N/A
1-Year Return 12.14% -14.17% Choksi Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.58 2.56 Choksi Laboratories Ltd.
Enterprise Value $988.26M $21.08B Krsnaa Diagnostics Ltd.
EV/Revenue Ratio 2.22 2.75 Choksi Laboratories Ltd.
Gross Profit Margin (TTM) 80.48% 70.12% Choksi Laboratories Ltd.
Revenue per Share (TTM) $64 $237 Krsnaa Diagnostics Ltd.
Earnings per Share (Diluted) $2.68 $24.48 Krsnaa Diagnostics Ltd.
Beta (Stock Volatility) 0.06 -0.03 Krsnaa Diagnostics Ltd.

Choksi Laboratories Ltd. vs Krsnaa Diagnostics Ltd. Stock Performance Analysis

Loading Price Chart...

CHOKSILA
KRSNAA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Choksi Laboratories Ltd.2.83%-7.99%21.15%31.75%-6.05%-3.17%
Krsnaa Diagnostics Ltd.0.32%0.47%-8.16%-10.16%-29.42%-26.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Choksi Laboratories Ltd.12.14%183.17%859.21%968.12%807.14%566.67%
Krsnaa Diagnostics Ltd.-14.17%-2.87%-40.72%-40.72%-40.72%-40.72%

Performance & Financial Health Analysis: Choksi Laboratories Ltd. vs Krsnaa Diagnostics Ltd.

MetricCHOKSILAKRSNAA
Market Information
Market Cap i₹703.84M₹19.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i2,10548,338
90 Day Avg. Volume i4,08967,120
Last Close₹125.45₹542.75
52 Week Range₹81.85 - ₹236.70₹515.00 - ₹894.40
% from 52W High-47.00%-39.32%
All-Time High₹236.70 (Aug 20, 2025)₹1,099.70 (Aug 16, 2021)
% from All-Time High-47.00%-50.65%
Growth Metrics
Quarterly Revenue Growth0.04%0.04%
Quarterly Earnings Growth1.93%-0.22%
Financial Health
Profit Margin (TTM) i0.04%0.10%
Operating Margin (TTM) i0.07%0.13%
Return on Equity (TTM) i0.06%0.09%
Debt to Equity (MRQ) i120.1630.96
Cash & Liquidity
Book Value per Share (MRQ)₹35.41₹284.46
Cash per Share (MRQ)₹0.45₹40.22
Operating Cash Flow (TTM) i₹51.38M₹2.45M
Levered Free Cash Flow (TTM) i₹15.23M₹776.08M
Dividends
Last 12-Month Dividend Yield iN/A0.62%
Last 12-Month Dividend iN/A₹5.25

Valuation & Enterprise Metrics Analysis: Choksi Laboratories Ltd. vs Krsnaa Diagnostics Ltd.

MetricCHOKSILA (Apr 26, 2026)KRSNAA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i37.7124.69
Forward P/E iN/A14.79
PEG Ratio i0.19-1.15
Price to Sales (TTM) i1.582.56
Price to Book (MRQ) i2.852.13
Market Capitalization
Market Capitalization i₹703.84M₹19.83B
Enterprise Value i₹988.26M₹21.08B
Enterprise Value Metrics
Enterprise to Revenue i2.222.75
Enterprise to EBITDA i8.8610.20
Risk & Other Metrics
Beta i0.06-0.03
Book Value per Share (MRQ) i₹35.41₹284.46

Financial Statements Comparison: Choksi Laboratories Ltd. vs Krsnaa Diagnostics Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCHOKSILA (2025)KRSNAA (2025)
Revenue/Sales i417.82M7.17B
Cost of Goods Sold i46.20M2.30B
COGS % of Revenue i11.1%32.1%
Gross Profit i371.62M4.87B
Gross Margin i88.9%67.9%
Research & Development iN/AN/A
Operating Income (EBIT) i50.09M1.02B
Operating Margin i12.0%14.2%
EBITDA i115.12M2.08B
EBITDA Margin i27.6%29.0%
Pre-Tax Income i21.53M1.03B
Pre-Tax Income % of Revenue i5.2%14.3%
Income Tax i6.30M250.79M
Income Tax % of Revenue i1.5%3.5%
Net Income (Profit) i15.23M776.08M
Profit Margin i3.6%10.8%

Balance Sheet & Liquidity Metrics

MetricCHOKSILA (2025)KRSNAA (2025)
Cash & Equivalents i6.12M38.46M
Total Current Assets i163.21M4.14B
Total Current Assets % of Revenue i39.1%57.8%
Total Current Liabilities i238.75M3.05B
Total Current Liabilities % of Revenue i57.1%42.6%
Long-Term Debt i159.63M471.56M
Long-Term Debt % of Revenue i38.2%6.6%
Total Shareholders Equity i236.05M8.83B
Retained Earnings i150.56M2.00B
Retained Earnings % of Revenue i36.0%28.0%
Property, Plant & Equipment i471.35M256.28M

Cash Flow Statement Comparison

MetricCHOKSILA (2025)KRSNAA (2025)
Operating Cash Flow i51.38M2.45M
Operating Cash Flow % of Revenue i12.3%0.0%
Capital Expenditures i-74.37M-1.12B
Free Cash Flow i40.91M-393.00M
FCF Margin i9.8%-5.5%
Debt Repayment i-58.75MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCHOKSILAKRSNAA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.97M32.44M
Float Shares i3.14M17.39M
% Held by Insiders i60.49%44.56%
% Held by Institutions i0.00%14.97%
% Held by Public i39.51%40.47%

Dividend Analysis & Yield Comparison: Choksi Laboratories Ltd. vs Krsnaa Diagnostics Ltd.

MetricCHOKSILAKRSNAA
Last 12-Month Dividend iN/A₹5.25
Last 12-Month Dividend Yield iN/A0.62%
3-Year Avg Annual Dividend iN/A₹3.50
3-Year Avg Dividend Yield iN/A0.39%
3-Year Total Dividends iN/A₹10.50
Ex-Dividend DateN/ASep 12, 2025